| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
|
Lancet
|
2006
|
12.98
|
|
2
|
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.
|
Lancet
|
2007
|
6.76
|
|
3
|
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.
|
Ann Intern Med
|
2006
|
4.52
|
|
4
|
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
|
J Clin Oncol
|
2010
|
4.01
|
|
5
|
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.
|
J Heart Lung Transplant
|
2013
|
2.71
|
|
6
|
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.
|
J Clin Oncol
|
2006
|
2.66
|
|
7
|
Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury.
|
Ann Thorac Surg
|
2005
|
2.15
|
|
8
|
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.
|
Clin Cancer Res
|
2009
|
1.99
|
|
9
|
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.
|
Clin Cancer Res
|
2007
|
1.94
|
|
10
|
Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors.
|
Clin Cancer Res
|
2010
|
1.89
|
|
11
|
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.
|
J Clin Oncol
|
2012
|
1.84
|
|
12
|
Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors.
|
Clin Cancer Res
|
2009
|
1.63
|
|
13
|
A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.
|
J Natl Cancer Inst
|
2008
|
1.63
|
|
14
|
Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
|
Ann Thorac Surg
|
2012
|
1.55
|
|
15
|
Small molecule tyrosine kinase inhibitor and depression.
|
J Clin Oncol
|
2008
|
1.51
|
|
16
|
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
|
Cancer
|
2014
|
1.43
|
|
17
|
Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices.
|
ASAIO J
|
2015
|
1.39
|
|
18
|
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.
|
Clin Cancer Res
|
2009
|
1.37
|
|
19
|
Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease.
|
Curr Opin Gastroenterol
|
2007
|
1.16
|
|
20
|
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.
|
Mt Sinai J Med
|
2004
|
1.13
|
|
21
|
Leiomyosarcoma of the inferior vena cava: survival after aggressive management.
|
Ann Surg Oncol
|
2007
|
1.10
|
|
22
|
Multimodality treatment of mesenteric desmoid tumours.
|
Eur J Cancer
|
2008
|
1.09
|
|
23
|
Imaging features of bone metastases in patients with gastrointestinal stromal tumors.
|
Diagn Interv Radiol
|
2012
|
1.06
|
|
24
|
Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
|
Eur J Cancer
|
2009
|
1.04
|
|
25
|
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).
|
PLoS One
|
2012
|
1.03
|
|
26
|
Implantation of a left ventricular assist device and the hub-and-spoke system in treating acute cardiogenic shock: who survives?
|
J Thorac Cardiovasc Surg
|
2003
|
1.01
|
|
27
|
Epithelioid angiosarcoma of the uterus: a review of management.
|
Arch Gynecol Obstet
|
2008
|
1.01
|
|
28
|
Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate.
|
Ann Surg Oncol
|
2009
|
1.00
|
|
29
|
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
|
Cancer
|
2002
|
0.98
|
|
30
|
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
|
Cancer
|
2013
|
0.95
|
|
31
|
A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.
|
Cancer
|
2004
|
0.94
|
|
32
|
Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial.
|
Cancer
|
2007
|
0.92
|
|
33
|
A phase I study of the HSP90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft-tissue sarcomas.
|
Clin Cancer Res
|
2013
|
0.89
|
|
34
|
Left internal thoracic artery-radial artery composite grafts as the technique of choice for myocardial revascularization in elderly patients: a prospective randomized evaluation.
|
J Thorac Cardiovasc Surg
|
2004
|
0.89
|
|
35
|
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
|
BMC Cancer
|
2014
|
0.88
|
|
36
|
Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database.
|
J Thorac Cardiovasc Surg
|
2010
|
0.87
|
|
37
|
Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
|
Artif Organs
|
2014
|
0.87
|
|
38
|
A case of an anomalous superior vena cava with anomalous pulmonary veins-when two wrongs do not make a right.
|
Echocardiography
|
2011
|
0.86
|
|
39
|
Edge-to-edge mitral valve repair: the Columbia Presbyterian experience.
|
Ann Thorac Surg
|
2004
|
0.83
|
|
40
|
The BICIRCUIT system: innovative perfusional options for surgical treatment of the thoracic aorta.
|
Ann Thorac Surg
|
2005
|
0.83
|
|
41
|
Sex-specific outcomes in patients receiving continuous-flow left ventricular devices as a bridge to transplantation or destination therapy.
|
ASAIO J
|
2014
|
0.82
|
|
42
|
Outcomes of patients with right ventricular failure on milrinone after left ventricular assist device implantation.
|
ASAIO J
|
2015
|
0.82
|
|
43
|
Lessons learned from 150 continuous-flow left ventricular assist devices: a single institutional 7 year experience.
|
ASAIO J
|
2015
|
0.82
|
|
44
|
Transportation of peripheral blood progenitor cell products: effect of ambient temperature.
|
Cytotherapy
|
2010
|
0.82
|
|
45
|
Measurement of Troponin T and I to detect cardioprotective effect of aminophylline during coronary artery bypass grafting.
|
Interact Cardiovasc Thorac Surg
|
2003
|
0.80
|
|
46
|
Continuous-flow left ventricular assist device implantation as a bridge to transplantation or destination therapy: racial disparities in outcomes.
|
J Heart Lung Transplant
|
2012
|
0.80
|
|
47
|
Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor.
|
J Neurooncol
|
2006
|
0.79
|
|
48
|
Should HIV-positive recipients undergo heart transplantation?
|
J Thorac Cardiovasc Surg
|
2003
|
0.79
|
|
49
|
Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support.
|
ASAIO J
|
2013
|
0.79
|
|
50
|
Seven-year disease-free survival after radical pneumonectomy for a pulmonary artery sarcoma.
|
J Thorac Cardiovasc Surg
|
2013
|
0.79
|
|
51
|
Effects of resveratrol in storage solution on adhesion molecule expression and nitric oxide synthesis in vein grafts.
|
Ann Thorac Surg
|
2005
|
0.77
|
|
52
|
Cardiac transplantation in an HIV-1-infected patient.
|
N Engl J Med
|
2003
|
0.76
|
|
53
|
Indigent men's use of emergency departments over primary care settings.
|
Am J Public Health
|
2004
|
0.75
|
|
54
|
Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival.
|
Int J Artif Organs
|
2014
|
0.75
|
|
55
|
Preservation of the anterior fat pad and incidence of postoperative atrial fibrillation following coronary surgery.
|
J Am Coll Cardiol
|
2005
|
0.75
|
|
56
|
Nonidentical Continuous-Flow Devices For Biventricular Support.
|
Tex Heart Inst J
|
2017
|
0.75
|
|
57
|
Efficacy of the "box" lesion pattern in the treatment of atrial fibrillation in the presence of mitral valve disease.
|
Ann Thorac Surg
|
2004
|
0.75
|
|
58
|
Is resternotomy a risk for continuous-flow left ventricular assist device outcomes?
|
J Card Surg
|
2012
|
0.75
|
|
59
|
Cardiac pheochromocytoma presenting as shortness of breath.
|
Am J Med
|
2009
|
0.75
|
|
60
|
Adhesiolysis is facilitated by robotic technology in reoperative cardiac surgery.
|
Ann Thorac Surg
|
2005
|
0.75
|
|
61
|
Ischemic versus nonischemic dilated cardiomyopathy: the implications of heart failure etiology on left ventricular assist device outcomes.
|
ASAIO J
|
2013
|
0.75
|
|
62
|
Separation of mediastinal shed blood during aortic valve surgery elicits a reduced inflammatory response.
|
J Cardiovasc Med (Hagerstown)
|
2016
|
0.75
|
|
63
|
Effect of Preoperative Albumin Levels on Outcomes in Patients Undergoing Left Ventricular Device Implantation.
|
ASAIO J
|
2015
|
0.75
|
|
64
|
Type A aortic dissection presenting with isolated paraplegia.
|
Heart Surg Forum
|
2012
|
0.75
|
|
65
|
Does a pre-left ventricular assist device screening score predict long-term transplantation success? A 2-center analysis.
|
Heart Surg Forum
|
2006
|
0.75
|
|
66
|
Method of treating patients with acute type A aortic dissection and lower extremity malperfusion.
|
J Card Surg
|
2014
|
0.75
|
|
67
|
Magnetic resonance imaging to detect acute cerebral events in on-pump and hybrid-pump patients.
|
Heart Surg Forum
|
2004
|
0.75
|
|
68
|
Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis.
|
ASAIO J
|
2016
|
0.75
|